期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

宫颈癌腔内治疗下评估靶区和危及器官的剂量与体积 被引量：3

原文传递
导出
摘要 世界每年新发宫颈癌患者约为50万人，仅次于乳腺癌；其中，我国新发病例15万人，约占全球的1／3，且近年来发病率有上升趋势，为我国妇科恶性肿瘤第,
作者 孙宝胜 左雅芳 田琦 欧健 张国胜 刘江山 刘士新
机构地区 吉林省肿瘤医院放疗四科
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2013年第1期66-67,共2页 Chinese Journal of Radiological Medicine and Protection
关键词 宫颈癌 危及器官 腔内治疗 体积 剂量 靶区 评估 妇科恶性肿瘤
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1徐晓颖,李秀荣,隋美玲,薛忠伟.盆腔体外联合腔内放射治疗宫颈癌72例临床疗效分析[J].大连医科大学学报,2009,31(5):541-544. 被引量：3
  • 2叶伟军,曹新平,李爱菊,任玉峰,陈凯,张志斌.插植调强近距离放射治疗复发性宫颈癌的临床研究[J].中华肿瘤防治杂志,2009,16(18):1427-1429. 被引量：19
  • 3李莎,田种泽,岳养军,魏世华,薛龙,朱向辉,赵瑞.复发性宫颈癌组织间插植并腔内近距离调强适形放射治疗效果分析[J].中华临床医师杂志（电子版）,2011,5(7):1896-1900. 被引量：10
  • 4梁保辉,郑传城,文万信.放疗肿瘤体积演变测量与分析[J].中国医学物理学杂志,2010,27(3):1851-1854. 被引量：4
  • 5Susan B, Peter B, Gerry L, et al. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. Int J Radiat Oncol Biol Phys, 2005, 63(1) : 934-939.
  • 6Dimopouios JC, Kirisits C, Petrie P, et al. The Vienna applicator for combined intraeavitary and interstitial braehytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oneol Biol Phys,2006,66 ( 1 ) : 83-90.
  • 7Akilan K. Tomography versus magnetic resonance imaging-based contouring in cervical cancer brachy-therapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oneol Biol Phys ,2007 ,68 (2) : 491-498.
  • 8Christian K, Stefan L, Johannes D, et al, The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning and dosimetric results. Int J Radiat Oncol Biol Phys, 2006,65 (2) : 624-630.
  • 9Christian K, Richard P, Stefan L, et al. Dose and volume parameters for MRI-based treatment planning in intercavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phi's, 2005,62(3) : 901-911.
  • 10Firuza D, Bhavana R, Indranil M, et al. High-dose-rate hrachytherapy in uterine cervical carcinoma. Int J Radiat Oncol Biol Phys ,2005,62 ( 1 ) : 125-130.

二级参考文献45

  • 1杨晓霞,韩云青.24例复发宫颈癌的化疗疗效分析[J].医药论坛杂志,2005,26(9):32-33. 被引量：4
  • 2姚志伟,刘楠,成慧君,谢翠峰.放射治疗子宫颈癌580例临床分析[J].中国实用妇科与产科杂志,2005,21(7):436-437. 被引量：11
  • 3马绍康,高菊珍,吴令英,王亚菲,张宏志,黄曼妮.宫颈癌复发肿瘤适形照射联合化疗30例临床观察[J].中国肿瘤临床,2006,33(2):96-98. 被引量：25
  • 4李魁秀,房朝辉,牛书怀,宋藏珠,樊晓妹.112例年轻妇女子宫颈癌放疗疗效及预后[J].中华放射肿瘤学杂志,2007,16(2):118-120. 被引量：7
  • 5闻强,朱笕青.晚期或复发宫颈癌化疗进展[J].国外医学（妇产科学分册）,2007,34(3):180-183. 被引量：8
  • 6Lorvidhaya V,Tonusin A,ChangwiwitW,et al.High dose rate afterloading brachytherapy in carcinoma of the cervix:an experience of 1992 patients[J].Int J Radiat Oncol Biol Phys,2000,46 (5):1185-1191.
  • 7D Utzig HG,Strauss J,Dunst G,et al.Definitive radiotherapy for cervical cancer:retrospective analysis of 444 patients treated with? external beam-radiotherapy (EBRT) and high-dose-rate afterloading(HDR)with more than 5 years follow-up[J].Int J Radiat Oncol Biol Phys,2002,54(2),42-45.
  • 8Kagei K,Shirato H,Nishioka T,et al.High dose rate intracavitary irradiation using linear source arrangement for stage Ⅱ and Ⅲ squamous cell carcinoma of the uterine cervix[J].Radiother Oncol,1998,47(2):207-213.
  • 9Takafumi T,Hidehiko M,Kazuhiko O,et al.Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterinecervical cancer[J].Gynecologic Oncol,2005,96(3),665-670.
  • 10Pettersson F. Annual report on the results of treatment in gynecological cancer[J]. Stockholm: FIGO, 1988,20.

共引文献27

同被引文献23

  • 1拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量：81
  • 2Monsonego J. HPV infections and cervical cancer prevention. Priorities and new directions[J]. Gynecol Oncol, 2005,96(3) : 830-839.
  • 3Wiley D, Masongsong E. Human papillomavirusthe burden of infection[J]. Obstet Gynecol Surv, 2006,61 ( 6 Suppl 1) : S3-14.
  • 4Munoz N, Bosch FX, de Sanjosfi S, et al. Epidemiologic classi- fication of human papitlomavirus types associated with cervical cancer[J]. N Engl J Med, 2003,348(6) :518-527.
  • 5Jones EE, Wells SI.Cervical cancer and human papillomavirus- esinactivation of retinoblastoma and other tumor suppressor pathways[J]. Curr Mol Med, 2006,6 (7) : 795-808.
  • 6Ferenczy A, Franco E. Persistent human papillomavirus infec- tion and cervical neoplasia[ J]. Lancet Oncol, 2002, 3 ( 1 ) :11-16.
  • 7Yamato K, Fen J, Kobuchi H, et al. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA[J]. Cancer Gene' Ther, 2006,13(3) : 234-41.
  • 8DeFilippis RA, Goodwin EC, Wu L, et al. Endogenous human papillomavirus E6 and E7 proteins differentially regulate pro- liferation, senescence, and apoptosis in HeLa cervical carcinoma cells[J]. J Virol. 2003, 77(2):1551-1563.
  • 9Thierry F, Benotmane MA, Demeret C, et al. A genomic ap- proach reveals a novel mitotic pathway in pap illamavirus car- cinogenesis[J].Cancer Res, 2004,64 (3): 895-903.
  • 10熊光武,袁杨,李萌,郭红燕,张小为.北京地区宫颈癌HPV16上游调控序列、E6、E7癌基因序列初步分析[J].遗传,2010,32(4):339-347. 被引量：17

引证文献3

二级引证文献18

中华放射医学与防护杂志
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部